 |
|
|
|
|
|
|
|
|
|
|
|
1 to 8 of 8 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Kayed R. on PAPER: Langer F. et al., 2011, This well-designed study is an extension of the previous outstanding studies published by... 18 Oct 2011.
|
|
|
 |
|
|
Kayed R. on PAPER: Boutajangout A. et al., 2010, Boutajangout et al. demonstrate that targeting phosphorylated tau by active immunization... 21 Dec 2010.
|
|
|
|
|
|
Kayed R, Lasagna C. on PAPER: Gandy S. et al., 2010, It is time to say that the large, easy-to-detect plaques are outdated. An emerging body of... 15 Oct 2010.
|
|
|
|
|
|
Kayed R. on PAPER: Hu X. et al., 2009, This is an interesting study. The ability to visualize intracellular accumulation of Aβ after... 17 Nov 2009.
|
|
|
|
|
|
Kayed R. on NEWS: Protein Aggregation In Disease—A New Theory Joins the Fold, The authors have elegantly demonstrated the importance of the presence of intracellular... 15 Feb 2006.
|
|
|
|
|
|
Glabe C, Kayed R. on PAPER: Racke MM. et al., 2005, Are conformation-dependent antibodies the key to a safe and effective AD... 11 Feb 2005.
|
|
|
|
|
|
Kayed R. on PAPER: Shorter J. et al., 2004, New Study Clarifies How Hsp104 Regulates Yeast Prions and Highlights the Role of Oligomers in... 2 Jun 2004.
|
|
|
|
|
|
Glabe C, Kayed R. on NEWS: Antibodies Found That Specifically Target Infectious Prions, This is an excellent paper; the data about the specificity of the antibody are quite convincing.... 13 Jun 2003.
|
|
|
|
|
|
|
1 to 8 of 8 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
